301331 恩威医药
2024/03 -
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资3740.00%374352419854
投资性房地产30,274-1.94%30,87333,27035,66738,064
固定资产216,490-1.88%220,638204,314217,927177,401
在建工程20,867136.64%8,81835,68423,84346,745
无形资产144,016-2.72%148,04442,08347,45352,257
商誉100,5530.00%100,553100,553100,553100,553
其他非流动资产46,58112.68%41,33832,53729,46224,197
559,1541.55%550,638448,793455,323440,071

流动资产
货币资金221,123-6.35%236,121341,57864,25063,019
应收账款97,8025.05%93,09698,33174,64072,594
存货127,60818.85%107,367104,646110,01278,337
其他流动资产349,850-0.12%350,276412,732164,864194,835
796,3841.21%786,859957,287413,767408,785

流动负债
短期借款0--0000
应付票据0--0000
应付帐款48,54556.90%30,94136,87633,64145,953
其他流动负债170,621-4.59%178,832190,708165,577188,227
219,1664.48%209,773227,584199,218234,180
流动资产净值577,2180.02%577,086729,703214,548174,605
资产总额减流动负债1,136,3710.77%1,127,7251,178,496669,871614,676

非流动负债
长期借款33,000--0000
应付债券0--0000
其他非流动负债23,819-2.93%24,53925,49327,62028,160
56,819131.55%24,53925,49327,62028,160

总权益
    实收股本70,1380.00%70,13870,13852,59852,598
    储备项目1,009,414-2.29%1,033,0481,082,865589,653533,919
股东权益1,079,552-2.14%1,103,1861,153,003642,252586,517
非控股权益0--0000